Proteon Therapeutics (PRTO) IPO Opens Higher
Get Alerts PRTO Hot Sheet
Join SI Premium – FREE
Today's IPO for Proteon Therapeutics Inc. (NASDAQ: PRTO) opened for trading at $11.30 after pricing 6,110,000 shares of its common stock at a public offering price of $10.00 per share, which was below the expected $12-$14 range. The offering size was raised from 4,700,000 shares.
Stifel and JMP Securities are acting as joint book-running managers for the offering, and Baird and Oppenheimer & Co. are acting as co-managers for the offering.
Proteon Therapeutics Inc. is developing novel, first-in-class pharmaceuticals to address the medical needs of patients with kidney and vascular diseases. The company is headquartered in Waltham, Mass.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veg House Holdings (VEG) Announces 1M Share IPO at $5/sh
- Meta Platforms Inc. (META) PT Lowered to $525 at JMP Securities, 'Meta Is Entering an AI Investment Cycle but Growth Catalysts Remain'
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
Create E-mail Alert Related Categories
IPOsRelated Entities
Robert W Baird, JMP Securities, IPOSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!